Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 3241 to 3255 of 7685 results

  1. Screening: cervical screening (25 to 49 years) (IND176)

    This indicator covers the proportion of patients eligible for cervical screening and aged 25 to 49 years at end of period reported whose notes record that an adequate cervical screening test has been performed in the previous 3.5 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM154

    General practice indicators suitable for use in QOF
    Published
    31 July 2017

  2. Interventional procedures advisory committee members

    Interventional Procedures Advisory Committee members

  3. Intrabeam radiotherapy system for adjuvant treatment of early breast cancer . Patient decision aid on intrabeam radiotherapy for treating early breast cancer

    Decision aid for Intrabeam radiotherapy system for adjuvant treatment of early breast cancer, TA501 c NICE 2018. All rights reserved. Subject to...

  4. Study NICE and LSE's Executive MSc Healthcare Decision-Making

    Study NICE and LSE's Executive MSc Healthcare Decision-Making

  5. Kidney conditions: CKD - ACEi and ARB (IND263)

    This indicator covers the percentage of patients on the CKD register and with an albumin to creatinine ratio (ACR) of 70 mg/mmol or more, without diabetes, who are currently treated with an ARB or an ACE inhibitor. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM247

    General practice indicators suitable for use outside of QOF
    Published
    21 August 2023

  6. Technology appraisal and highly specialised technologies appeals

    Technology appraisal and Highly specialised technologies appeals

  7. Past appeals and decisions

    Down to Rejected appeals Cancelled appeals Past appeals TA ID Appraisal short title Appeal hearing date TBC Afamelanotide for erythropoietic

  8. NICE Advice service

    NICE Advice is an advisory service for pharmaceutical and healthtech companies seeking to enter the NHS market, and supporting organisations who fund or generate evidence for health technologies.

  9. Standards and Indicators

    NICE quality standards set out priority areas for quality improvement in health and social care.

  10. Terms and conditions

    Terms and conditions for the National Institute for Health and Care Excellence

  11. CKS end user licence agreement

    CKS end user licence agreement

  12. Transport Layer Security (TLS) 1.2 upgrade

    Information about transport layer security (TLS) 1.2 upgrade

  13. Structure of NICE

    Our board sets out our strategic priorities and policies. The day to day decision-making is the responsibility of our executive team . The...

  14. Environmental sustainability

    NICE is committed to supporting the national agenda for achieving a sustainable health and care system.

  15. 5-year equality, diversity and inclusion (EDI) roadmap and annual action plan

    We're committed to creating a forward-looking, positive work culture where everyone can thrive. Our 5-year equality, diversity and inclusion (EDI)...